Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide notice about intermittent delays was added. The revision version was updated from v3.6.4 to v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-13T18:38:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This indicates a minor metadata update to the record rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-07-23T08:54:57.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    No additions or deletions were reported; there are no textual updates to summarize.
    Difference
    0.1%
    Check dated 2026-07-16T08:28:26.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new revision tag v3.6.3 was added to the page, replacing the previous v3.6.1. This indicates an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-02T03:24:56.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.6.1 is now shown instead of v3.6.0, indicating a small page template update rather than substantive changes to the study record. No study data or navigation elements appear to be altered.
    Difference
    0.1%
    Check dated 2026-06-25T00:24:07.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page now indicates enrollment is closed to new participants ('No longer looking for participants') and adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). A minor formatting change updates the Intervention/Treatment heading (from 'Intervention / Treatment') and the revision label to v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-18T02:13:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.